DNA methylation of tumor suppressor genes is a frequent mechanism of transcriptional silencing in cancer. The molecular mechanisms underlying the specificity of methylation are unknown. We report here that the leukemia-promoting PML-RAR fusion protein induces gene hypermethylation and silencing by recruiting DNA methyltransferases to target promoters and that hypermethylation contributes to its leukemogenic potential. Retinoic acid treatment induces promoter demethylation, gene reexpression, and reversion of the transformed phenotype. These results establish a mechanistic link between genetic and epigenetic changes during transformation and suggest that hypermethylation contributes to the early steps of carcinogenesis.

Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor / L. Di Croce, V. A. Raker, M. Corsaro, F. Fazi, M. Fanelli, M. Faretta, F. Fuks, F. Lo Coco, T. Kouzarides, C. Nervi, S. Minucci, P. G. Pelicci. - In: SCIENCE. - ISSN 0036-8075. - 295:5557(2002 Feb 08), pp. 1079-82-1082. [10.1126/science.1065173]

Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor

S. Minucci;P. G. Pelicci
Ultimo
2002

Abstract

DNA methylation of tumor suppressor genes is a frequent mechanism of transcriptional silencing in cancer. The molecular mechanisms underlying the specificity of methylation are unknown. We report here that the leukemia-promoting PML-RAR fusion protein induces gene hypermethylation and silencing by recruiting DNA methyltransferases to target promoters and that hypermethylation contributes to its leukemogenic potential. Retinoic acid treatment induces promoter demethylation, gene reexpression, and reversion of the transformed phenotype. These results establish a mechanistic link between genetic and epigenetic changes during transformation and suggest that hypermethylation contributes to the early steps of carcinogenesis.
DNA (Cytosine-5-)-Methyltransferase; Gene Silencing; Humans; Gene Expression; Promoter Regions, Genetic; Receptors, Retinoic Acid; DNA Methylation; Transcription Factors; Tumor Cells, Cultured; Zinc; Azacitidine; Leukemia, Promyelocytic, Acute; Oncogene Proteins, Fusion; Exons; Histone Deacetylases; Cell Differentiation; Recombinant Fusion Proteins; Cell Nucleus; Cloning, Molecular; Binding Sites; Neoplasm Proteins; CpG Islands; Tretinoin; Mutation; Cell Transformation, Neoplastic; Cell Line
Settore MED/04 - Patologia Generale
8-feb-2002
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/194922
Citazioni
  • ???jsp.display-item.citation.pmc??? 195
  • Scopus 702
  • ???jsp.display-item.citation.isi??? 629
social impact